Zdrowie i gospodarka · 03/06/2026
FDA Releases Revised Draft Guidance for Industry on Communications with Payors and Formulary Committees
The FDA is releasing a revised draft guidance for industry regarding communication with payors, formulary committees, and similar entities about approved prescription drugs and medical devices. The guidance aims to provide answers to common questions about sharing health care economic information with these entities.